Business Context and Reporting Period
Company: Alkermes Plc.
Filing Type: Form 8-K (Current Report)
Date of Report: October 12, 2016
Event: Entry into a Definitive Material Agreement regarding the amendment of the company's credit facility.
Key Financial Metrics
The filing does not provide comprehensive financial statements (revenue, profit, cash flow, or margins). Specific debt metrics disclosed include:
- Outstanding Term Loan: Approximately $286 million.
- Interest Rate: Unchanged from existing terms.
- Lenders: Morgan Stanley Senior Funding, Inc. (Administrative Agent), Citigroup Global Markets, Inc., and JPMorgan Chase Bank, N.A.
Material Changes Versus Prior Period
The primary material change is the extension of the maturity date for the outstanding term loan:
- Previous Maturity Date: September 25, 2019 (implied by the two-year extension).
- New Maturity Date: September 25, 2021.
- Modification: The Amendment extends the loan term by two years and includes certain other modifications to the Credit Agreement.
Guidance, Outlook, and Risks
Management Commentary: The filing focuses solely on the execution of the Amendment to the Amended and Restated Credit Agreement. No forward-looking guidance, revenue outlook, or strategic commentary is provided in this specific document.
Risks and Contingencies: The filing does not explicitly detail new risks or contingencies beyond the standard obligations of the amended credit agreement.
Important Facts for Investor Verification
- Verify the total debt load and liquidity position in the most recent 10-Q or 10-K to contextualize the $286 million term loan.
- Confirm the specific "other modifications" to the Credit Agreement mentioned in the filing, as they are not detailed in this summary.
- Review the company's cash flow projections to ensure the extended maturity date aligns with long-term repayment capabilities.
- Check for any covenant changes associated with the amendment that could impact future financial flexibility.